Alia Therapeutics
  • Home
  • People
    • Board of Directors
    • Alia People
    • Scientific Advisors
    • Investors
  • Technology
  • Careers
  • News
  • Contact
Select Page

Press Releases

  • Alia Therapeutics celebrates the opening of its new headquarter and laboratory space within the new life science hub from Trentino Sviluppo S.p.A | Trentino Sviluppo S.p.A.
  • Alia Therapeutics appoints Adel Nada as Independent Board Director | Sofinnova Partners
  • Alia Therapeutics names Letizia Goretti as Chief Executive Officer | Sofinnova Partners
  • Alia Therapeutics secures €4.4 million seed financing extension led by Sofinnova Partners | Sofinnova Partners
  • Sofinnova Partners announces three new investments from its fund dedicated to Italian scientific research | Sofinnova Partners
  • Alia Therapeutics closes its seed funding round | BiovelocITA
  • Privacy policy
  • Cookie policy
  • Credits
This website uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the site does not require the user’s consent.
© 2024 Alia Therapeutics. All rights reserved. VAT 02522690227